Numerous lines of evidence indicate that some of the neurotoxicity associated with Alzheimer's disease (AD) is due to proteolytic fragments of the amyloid precursor protein (APP). Most research has focused on the amyloid ␤ peptide (A␤). However, the possible role of other cleaved products of APP is less clear. We have previously shown that a recombinant carboxy-terminal 105 amino acid fragment (CT 105) of APP induced strong nonselective inward currents in Xenopus oocyte; it also revealed neurotoxicity in PC12 cells and primary cortical neurons, blocked later phase of long-term potentiation in rat hippocampus in vivo, and induced memory deficits and neuropathological changes in mice. We report here that the pretreatment with CT 105 for 24 h at a 10 M concentration increases intracellular calcium concentration by about twofold in SK-N-SH and PC 12 cells, but not in U251 cells, originated from human glioblastoma. In addition, the calcium increase and toxicity induced by CT 105 were reduced by cholesterol and MK 801 in SK-N-SH and PC 12 cells, whereas the toxicity of A␤ 1-42 was attenuated by nifedipine and verapamil. CT 105 rendered SK-N-SH cells and rat primary cortical neurons more vulnerable to glutamate-induced excitotoxicity. Also, conformational studies using circular dichroism experiments showed that CT 105 has ϳ15% of ␤-sheet content in phosphate buffer and aqueous 2,2,2-trifluoroethanol solutions. However, the content of ␤-sheet conformation in dodecyl phosphocholine micelle or in the negatively charged vesicles, is increased to 22%-23%. The results of this study showed that CT 105 disrupts calcium homeostasis and renders neuronal cells more vulnerable to glutamate-induced excitotoxicity, and that some portion of CT 105 has partial ␤-sheet conformation in various environments, which may be related to the self-aggregation and toxicity. This may be significantly possibly involved in inducing the neurotoxicity characteristic of AD
neurons in vitro (8, 9) and in vivo (10, 11) . The toxicity of A␤ has been known to be related to some intrinsic ion channel activity (12) , reactive oxygen species (9) , and excessive Ca 2ϩ influx, altering neurotransmitter receptor function (13) and disrupting Ca 2ϩ homeostasis (8) . However, a relatively high concentration (Ͼ 20 M) of A␤ was needed to exert toxicity, and some studies failed to demonstrate the toxicity of A␤ in vivo (14) . It has been reported that under certain conditions in culture, A␤ promotes neurite outgrowth (13) instead of exerting toxic action. In addition, there are highly variable numbers of A␤-containing diffuse plaques in normal elderly people, and A␤ deposition has been observed in various brain areas without accompanying neurodegeneration (15) . Thus, A␤ may not be the sole fragment in the neurotoxicity associated with AD. Consequently, the possible effects of other cleavage products of APP need to be explored.
It was reported that carboxyl-terminal fragments of APP (CTs) are found in media and cytosol of lymphoblastoid cells obtained from patients with early-or late-onset familial AD (16) and Down's syndrome (17) . In addition, the carboxyl-terminal peptides have been identified in plaques, microvessels, and the neurofibrillary tangles in the brains of AD patients (18, 19) . These carboxyl-terminal fragments, which contain the complete A␤ sequence, appear to be toxic to neurons in culture, although the mechanism of action is not understood (20, 21) . Transgenic mice that overexpressed the CT 100 peptide (22) showed extensive neuronal degeneration in the hippocampal area (23) and cognitive impairment (24) . Recent work has reported that APP mutations that cause familial Alzheimer's disease increase the intracellular accumulation of potentially amyloidogenic and neurotoxic carboxyl-terminal fragments of APP in neurons (25) . This indicates that the carboxyl-terminal fragment of APP might be significantly involved in the pathogenesis in AD.
Because CT has been presumed to exert its toxic action through secondary generation of A␤, the role of CT peptide itself in the pathogenesis of AD is poorly understood.
We previously reported the neurotoxicity of a carboxy-terminal fragment of APP that may be released into the extracellular space (26, 27) and also shown that CT 105, a recombinant carboxyl-terminal 105 amino acid fragment of APP, induced strong nonselective inward currents in Xenopus oocytes (28) , Purkinje cells (29) , planar lipid bilayer (30) as well as memory deficits and neuropathological changes, characteristics of AD in mice (31) .
The secondary structure determines several important properties of peptides that may be relevant to the pathogenesis of neurodegenerative diseases. In the case of A␤, it has been demonstrated that the amyloid peptide is neurotoxic (9, 13, 32) and that this characteristic is associated with the formation of ␤-sheet or amyloid fibrils (33, 34) . The ability of A␤ to form fibrils is directly correlated with the content of ␤-sheet structures adopted by the peptide (35) . Polymerization of A␤ into protease-resistant fibrils is a significant step in the pathogenesis of AD (36) . CT is also reported to able to form self aggregates in vitro (26, 37) and in transfected cells (20, 38) . The main determinant of amyloid formation is the conformation adopted by the peptide in the stage before aggregation (39) .
In this study, we have investigated the effects of CT 105 on calcium homeostasis and glutamate-induced excitotoxicity in various cultured cells. We performed conformational studies of CT 105 using a circular dichroism (CD) technique to investigate the structural basis for CT aggregation and toxicity.
MATERIALS AND METHODS

Cell culture
The cerebral cortex was dissected out from embryonic day 19 Sprague-Dawley rat embryo and dissociated by gentle trituration. Cells were plated in 35 dishes coated with polyethylene (0.2 mg/ml in sodium borate buffer, pH 8.3) at a density of 2 ϫ 10 5 cells per dish. After overnight incubation in Dulbecco's modified Eagle's medium (DMEM; Life Technologies, Inc., Grand Island, N.Y.) supplemented with 10% fetal bovine serum, the medium was changed to serum-free defined medium for neurons [DMEM supplemented with 2 mM glutamine, 1 mM pyruvate, penicillin-streptomycin-amphotericin B mixture (Life Technologies, Inc.), 5 mM HEPES, 0.5% glucose, 10 g/ml insulin, 30 nM sodium selenite, 20 nM progesterone, 100 M putrescine, and 20 ng/ml transferrin]. The cultures were incubated at 37°C in 5% CO 2 and the medium was replaced every other day. Experiments were performed in 14-to 15-day-old cultures.
SK-N-SH cells originating from human neuroblastoma were purchased from Cell Bank of Seoul National University; PC 12 cells originating from rat pheochromocytoma (40) were obtained from Dr. Myung Goo-Lee; and U251 cells derived from human glioblastoma (41) were provided by Dr. Y. Sakaki. Cells were plated in polyethylene-coated coverslips and 96-well plates.
Preparation of recombinant CT 105
Recombinant CT 105 was prepared on the basis of human APP 770 cDNA as described previously (42) . Briefly, the expression plasmid pCS-CT 105 was constructed by ligating the 704 bp BglII-ClaI fragment excised from pSP65-APP 770 into ptrpSF9 (digested with BglII, SmaI and treated with CIAP) and transformed into Escherichia coli, XL1-Blue. CT 105 peptide (M r 14,242) was purified by a combination of urea solubilization and ion exchange chromatography and then subjected to dialysis against 10 mM Tris-HCl (pH 7.4), followed by lyophilization.
Determination of intracellular calcium concentration
The methods for the [Ca 2ϩ ] i measurements have been described (43) . Briefly, cultured cells were washed twice with Hank's solution and incubated at 37°C for 45 min in Hank's solution containing 10 M Fura-2/AM, 5 mM glucose, and 1 mM CaCl 2 . To remove the extracellular Fura-2/AM, the loaded cells were rinsed three times with the same solution. The cells were placed in a two wavelength microscopic fluorometer (InCytIm2; Intracellular Imaging Inc., Cincinnati, Ohio). Excitation wavelengths of 340 and 380 nm and an emission wavelength of 510 nm were used for the Fura-2 fluorescence. In all experiments, autofluorescence at both 340 and 380 nm wavelengths was extracted from the total fluorescence intensity increased by treated substances. The fluorescence ratio was obtained by dividing the fluorescence excited at 340 nm by that 380 nm, and the [Ca 2ϩ ] i was calculated based on the formula described by Grynkiewicz et al. (43) 
where Rmin is the ratio at zero calcium in the medium, and Rmax is the ratio at saturation calcium concentration. Fmin is the fluorescence at 380 nm at zero calcium concentration in the medium and Fmax is the fluorescence at 380 nm at saturation calcium concentration. The effective dissociation constant (K d ) of 224 nM for the Fura-2-Ca 2ϩ complex was used as reported by Grynkiewicz et al. (43) .
Calcium imaging by confocal laser scanning microscopy
The cells, pretreated with CT 105, were washed twice with Hank's solution and incubated for 20 min at 37°C in the same buffer containing 10 M Fluo-3/AM. Images were obtained using a laser-scanning confocal microscope (Bio-Rad MRC 1024) connected to an inverted microscope (Zeiss, Germany) fitted with a 10 ϫ 63 ϫ oil. Excitation was achieved using an Argon ion laser [wavelength ()ϭ488 nm] and fluorescence was measured at Ͼ515 nm. Changes of intracellular calcium levels were measured using relative fluorescence compared with that of control group.
Toxicity assay
The toxicities of CT 105 or A␤ or A␤ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] with or without cholesterol, MK 801, nifedipine, verapamil, and glutamate were assessed by lactate dehydrogenase (LDH) assay. After the appropriate incubation time with the peptides with or without the various agents listed above, LDH activities in the medium were measured by a Cytotox 96 nonradioactive cytotoxicity assay kit (Promega, Madison, Wis.) according to the manufacturer's instructions. The results were expressed as percentages of peak LDH release obtained on complete cell lysis.
Circular dichroism studies
Concentration of CT 105 for CD measurement was 0.05 mM. Sodium dodecyl sulfate, dodecyl phosphocholine (DPC) micelle solutions were prepared by dissolving appropriate amount of detergent in 50 mM phosphate buffer at pH 7.0. DPC was purchased from Avanti Polar Lipids (Birmingham, Ala.). PC and phosphatidylglycerol (PG) from egg yolk were purchased from Sigma (St. Louis, Mo.). Small unilamellar vesicles (SUV) of defined lipid composition were prepared by sonication technique described by Barenholtz et al. (44) . CT 105 and vesicles were incubated in 50 mM phosphate buffer (pH 7.0) for 20 -24 h at 25°C prior to CD measurement.
CD experiments were carried out on a Jasco J720 spectropolarimeter in the Korea Basic Science Institute. All measurements were performed at room temperature using quartz cells with a path length of 0.1 cm. Data were collected at 0.1 nm intervals and 8 scans were averaged with the scan rate of 100 nm/min. The spectra were corrected for buffer and vesicles after acquisition. The secondary contents were determined by computer fitting to a library of CD spectra using the learning neural network program K2D, which is based on the algorithm published previously (45) .
Statistical analysis
Statistical analysis was performed by Student's t test and ANOVA using an SPSS program (SPSS Inc., Chicago, Ill.) to study the relationship between the different variables. Values of PϽ0.05 were considered to indicate statistical significance.
RESULTS
The effects of CT 105 on intracellular calcium levels in SK-N-SH, PC 12, and U251 cell
The effect of CT 105 on the intracellular free calcium concentration was analyzed using Fura-2 dye method as described in Materials and Methods. Average intracellular calcium concentration of 53.4 Ϯ 7.5, 57.4 Ϯ 9.0, 54.8 Ϯ 6.8 nM/cell has been shown in SK-N-SH, PC 12, and U 251 cells, respectively. When cells were treated with 10 M of CT 105 for 24 h, SK-N-SH (originated from human neuroblastoma) and PC 12 cells (originated from rat pheochromocytoma) showed marked increase in intracellular calcium concentrations of 105.9 Ϯ 9.0 and 108.4 Ϯ 5.4 nM, respectively, whereas U251 cells (originating from human glioblastoma) showed no significant change (Fig. 1.) .
We have also shown the concentration-and timedependent changes of calcium levels with 10 M (Fig. 2a) . Pretreatment of SK-N-SH cells with 10 M of CT 105 for 1, 3, 6, 24 h induced a time-dependent increase in relative fluorescence by Fluo-3AM (Fig. 2b) .
To determine whether the elevations in intraneuronal calcium levels induced by CT 105 were due to extracellular calcium influx or not, we measured the change of intracellular calcium concentration and cell cytotoxicity using calcium-containing or calciumdeficient media in SK-N-SH cells. Calcium-deficient medium consisted of HBSS containing no added calcium. There was no change in intracellular calcium concentration in calcium-free media, whereas cells in normal media treated with 10 M CT 105 for 6 h showed significant increase in calcium concentration (data not shown), suggesting that calcium may enter the cells from outside. Also, cells in the calcium-deficient medium were protected against the neurotoxicity of CT 105 (data not shown). Thus, calcium influx should be necessary for the neuronal damage induced by CT 105.
The effects of neuroprotective agents on the increase in intracellular calcium concentration and cell toxicity induced by CT 105
To investigate the effects of neuroprotective agents on CT 105-induced neurotoxicity and calcium-increasing effect, we measured cell viability and changes in intracellular calcium concentration after pretreatment of 500 M of cholesterol, 100 M of MK-801 4 h before CT 105 treatment and 20 M of nifedipine and 25 M of verapamil 2 h before CT treatment in SK-N-SH and PC 12 cells. We measured cell viability after treating A␤ and A␤ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] with or without neuroprotective agents. Cholesterol signifi- cantly inhibited the CT 105-induced increase in intracellular calcium levels and cell toxicity and MK-801 attenuated intracellular calcium increase and cytotoxicity in SK-N-SH cells (Fig. 3, Fig. 4a) ; in the case of A␤ and A␤ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] , nifedipine and verapamil, specific blockers of voltage-sensitive calcium channels, protected A␤-induced toxicity in SK-N-SH (Fig. 4c) and PC 12 cells (data not shown), respectively. In PC 12 cells, cholesterol and MK 801 also reduced CT 105-induced cytotoxicity whereas nifedipine and verapamil did not (Fig. 4b) .
The effects of CT 105 on the glutamate-induced excitotoxicity
In this study, CT 105 enhanced glutamate-induced excitotoxicity in SK-N-SH cells and rat primary cortical neurons (Fig. 5, Fig. 6 ). When these cells were exposed to two concentrations of glutamate (100 M and 1 mM) and/or three concentrations of CT 105 (500 nM, 1 M, 5 M) for 24 h, neuronal survival was significantly reduced compared to cultured cells incubated in the presence of glutamate alone. With increasing concentrations of CT 105 from 500 nM to 5 M, there was a progressive enhancement of glutamate neurotoxicity (Fig. 5) . Phase-contrast micrographs in Fig. 6 show fields of cultured rat cortical primary neurons before and after exposure to 1 mM glutamate alone or with CT 105 1 M. The glutamate-induced neuronal degeneration, enhanced by CT 105, was characterized by vacuolation of the cell bodies, neurite fragmentation, and ultimately cell death (Fig. 6 ).
Conformational studies of CT 105 by CD spectroscopy
CD spectra of CT 105 in phosphate buffer, aqueous 2,2,2-trifluoroethanol (TFE) solution, and DPC micelle are presented in Fig. 7a . Table 1 lists the predicted secondary structure composition according to our CD data using the K2D learning neural network program. CT 105 adopts a partial ␣-helical conformation in phosphate buffer and 50%(v/v) aqueous TFE solution, with a helical content of 34% and 30%, respectively. In the case of DPC micelle, the content of ␤-sheet conformation of CT 105 in DPC micelle was 19%, 21%, and 23% in 10 mM, 50 mM, and 100 mM DPC micelles, respectively. Addition of NaCl (up to 100 mM) did not show any significant effects on the conformation of CT 105. CD spectrums of CT 105 in SUV are shown in Fig. 7b . In both vesicles, CT 105 has partial ␣-helical conformation, but in the presence of a negatively charged vesicle such as PC/PG (3:1) vesicle, the content of ␤-sheet conformation increased from 16% to 22%, as listed in Table 1 . CD results show that the ␤-sheet conformation of CT 105 may cause self-aggregation and cytotoxicity.
DISCUSSION
A␤ has been reported to exert toxicity on neurons in vitro (8, 9) and in vivo (10, 11, 46) . To date, most research has been focused on the toxicity of A␤ related to AD. However, as there are still some discrepancies between the deposition of A␤ and neuronal loss in AD, A␤ may not be the sole causative fragment in AD. Recent works have shown that CT fragments of APP are found in media and cytosol of lymphoblastoid cells obtained from patients with early-or late-onset familial AD (16) and Down's syndrome (17) . In addition, the CT peptide has been identified in plaques and microvessels and may be a constituent of the neurofibrillary tangles character- istic of AD (37) . These CT fragments of APP, which contain the complete A␤ sequence, appear to be toxic to neurons in culture, although the mechanism of action is not fully understood (38) . Furthermore, transgenic mice that overexpressed the CT 100 peptide (22) showed extensive neuronal degeneration in the hippocampal area (23) as well as cognitive impairments (24) and inhibition of long-term potentiation (LTP; 47). Because CT has been presumed to exert its toxic action through secondary generation of A␤, however, the role of CT peptide itself in the pathogenesis of AD is poorly understood.
Recent work has reported that APP mutations that cause familial Alzheimer's disease increase the intracellular accumulation of potentially amyloidogenic and neurotoxic carboxyl-terminal fragments of APP in neurons (25) . These results suggest that the carboxyl-terminal fragment of APP is significantly involved in the pathogenesis in AD, especially in familial AD.
We earlier reported that either extracellular or intracellular application of CT 105 elicited strong nonselective inward currents and toxic effects in Xenopus oocyte (28), rat Purkinje neuron (29) , PC 12, and cultured rat cortical cells (26) , and that CT might be released into the media (26) and may affect surrounding neurons and CT blocked LTP in rat hippocampus in vivo (48) and induced behavioral impairment and neuropathological changes in mice (31) .
In the present study, we focused on the effects of CT 105 on the intracellular calcium homeostasis and glutamate-induced excitotoxicity in various cultured cells. Alterations in calcium homeostasis can lead to intracellular calcium accumulation and trigger lethal process (49) . We demonstrate that the treatment cell. This result is consistent with our previous results that CT 105 directly damaged the cortical neurons and PC 12 cells but did not affect the viability of U 251 cells originating from human glioblastoma, suggesting a neuroselective toxic effect of CT 105 (26) . It has been reported that neuronal cells were much more sensitive to the toxic effects of amyloidogenic CT fragments. Neurons but not non-neuronal cells derived from a multipotent embryonic carcinoma cell line (P19 cells) and a morphologically heterogeneous neuroblastoma cell line (SK-N-SH) were vulnerable to overexpression of CT 99 (19) . The mechanism of cell type-dependent toxic effects of CT 105 is not clear. However, it is likely that CT 105 exerted a calcium homeostasis-destabilizing effect only on neuronal cell and not on non-neuronal cell, owing to the different membrane structure in neuronal cell and non-neuronal cell. In our results, cholesterol could significantly attenuate CT 105-induced neurotoxicity and increase in intracellular calcium levels, whereas the cytotoxicity induced by A␤ and A␤ [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] was significantly reduced by nifedipine and verapamil in SK-N-SH and PC 12 cells. This is consistent with the previous report by others that the neurotoxicity by A␤ was attenuated by nimodipine, a voltage-sensitive calcium channel blocker (50) . Taken together, these results can suggest that CT 105 and A␤ exert neurotoxic effects by different mechanisms. Although the mechanism whereby CTs destabilize calcium homeostasis is not known, several possibilities are worth considering.
CT was reported to form cation-selective ion channels in the planar lipid bilayer composed of palmitoyloleoylphosphatidylethanolamine and palmitoyloleoylphosphatidylcholine (80:20) (30) . The intracellular calcium-increasing effect of CT 105 shown in this study might be due to this channel-forming effect of CT 105. This channelforming effect could be strongly supported by results by Fraser et al. (28) , who reported that CT 105 induced strong nonselective inward currents in Xenopus oocyte.
In this study, there was no change in intracellular calcium concentration in calcium-free media, whereas cells in normal media treated with 10 M CT 105 for 6 h showed a significant increase in calcium concentration, suggesting that calcium may enter the cells from outside. Also, cells in the calcium-deficient medium were protected against the neurotoxicity of CT 105. Thus, calcium influx should be necessary for the increase in intracellular calcium and neuronal damage induced by CT 105.
Results showing that cholesterol, an agent that decreases membrane fluidity, could protect SK-N-SH and PC 12 cells from cell toxicity and calcium increase by CT 105 could support the hypothesis that CT 105 might increase calcium concentration by a channel-forming effect. Intracellular injection of CT 105 into Xenopus oocyte caused the same channel effects but to a greater extent than extracellular application of CT 105, suggesting that extracellular reflects an intracellular effect (28) . In this study, the increase in intracellular calcium and toxicity exerted by CT 105 in SK-N-SH and PC 12 cells was also attenuated by MK-801, a noncompetitive NMDA receptor antagonist, which raises the possibility that CT 105 might affect glutamate-gated calcium channels.
We had also reported that CT 105 inhibited calcium uptake into rat brain microsomes by Mg 2ϩ -Ca 2ϩ ATPase (51) and that CT 105 inhibits the activity of Na ϩ -Ca 2ϩ exchanger in SK-N-SH cells (52) . Alterations in neuronal Na ϩ -Ca 2ϩ exchange in AD have been reported (53) .
Taken together, our data suggest that increased calcium influx, inhibition of calcium efflux, and inhibition of calcium uptake into intracellular calcium storing organelles may contribute to the increase in intracellular calcium concentration and neurotoxicity induced by CT.
We also investigated the conformation of CT 105 using a CD experiment. CT 105 has a ␤-sheet conformation of ϳ20% in various solutions. As listed in Table 1 , the ␤-sheet content of CT 105 is larger in DPC micelle and anionic vesicles than that in aqueous solution. Since DPC micelle and unilamellar vesicles are good phospholipid-containing model membranes, this implies that interactions with the cell membrane induce more ␤-sheet structure in A␤-peptide-containing CT 105, which can induce self-aggregates similar to A␤. This conformation might have resistance to proteolysis by protease. Monomeric A␤ or A␤ is in a random coil or ␣-helical conformation and stimulates outgrowth in vitro (54) . A change into ␤-sheet conformation leads to the formation of fibrils and a concomitant toxic effects toward neurons in vitro (54, 55) . Transition to the ␤-sheet conformation proceeds faster below pH 6.5 and at an increased A␤ concentration (56, 57) . Furthermore, fibril formation accelerates upon nucleation, when initial fibrils have formed.
Taken together, these results might indicate that CT accumulated intra-or extracellularly by proteolytic processing of APP disrupts calcium homeostasis by different mechanisms in neuronal cells. Our unpublished data show that the CT deletion mutant without an A␤ region is also toxic to differentiated PC 12 cells and rat primary cortical neurons. Thus, these data raise the possibility that the toxicity by CT 105 is caused by an additive action of carboxylterminal ends without A␤ or A␤.
In conclusion, the demonstration for the first time of the calcium homeostasis-disrupting effect of CT 105 peptide would support the evidence for its involvement in neurodegeneration characteristic of AD. Also, it can be postulated that an altered processing or overproduction of APP could result in the intracellular production of the CT fragment, calcium homeostasis disruption, and triggering lethal process. The A␤-bearing CT fragment is not only the precursor of A␤ production, but is also a more active and toxic product than A␤. Internal CT fragments may be further metabolized to A␤, which is deposited in the brain where it inflicts additional toxicity to neurons.
